Preparation and investigation of tumor affinity, uptake kinetic and transport mechanism of iodine-123-labelled amino acid derivatives in human pancreatic carcinoma and glioblastoma cells.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Nuclear Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0969-8051(00)00176-1PMID 11182560
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ergebnisse der Positronen- emissionstomographie mit Fluor-18-markierter Fluordesoxyglukose bei Differentialdiagnose und Staging des Pankreaskarzinoms

  2013cited by this paper
• Amino acid transport in isolated rat hepatocytes

  2005cited by this paper
• Neutral amino acid transport in bovine articular chondrocytes

  1999cited by this paper
• Synthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors.

  1999cited by this paper
• Evaluation of l-3-[123I]iodo-α-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy

  1999cited by this paper
• Preclinical evaluation of 4-[18F]fluoroprolines: diastereomeric effect on metabolism and uptake in mice.

  1999cited by this paper
• Improved labelling of no-carrier-added 123I-MIBG and preliminary clinical evaluation in patients with ventricular arrhythmias.

  1999cited by this paper
• New preparation of (123I) iodolisuride from the 2-tri-n-butylstannalisuride derivative.

  1999cited by this paper
• Rational design of dynorphin A analogues with delta-receptor selectivity and antagonism for delta- and kappa-receptors.

  1998cited by this paper
• Rational design of dynorphin A analogues with δ-receptor selectivity and antagonism for δ- and κ-receptors

  1998cited by this paper
• Synthesis and biological activity of [Tic5] didemnin B.

  1998cited by this paper
• Preparation of 8-[3-(4-fluorobenzoyl)-propyl]-1-(4-[123I] iodobenzoyl)-1,3,8-triazaspiro[4,5]decan-4-one: a novel selective serotonin 5-HT2 receptor agent.

  1997cited by this paper
• 3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET.

  1997cited by this paper
• Inhibition of the cardiac sarcolemma Na+/Ca2+ exchanger by conformationally constrained small cyclic peptides.

  1997cited by this paper
• Effects of new endogenous nonprotein amino acids, 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives, on behavior of mice.

  1996cited by this paper
• Uptake of iodine-123-alpha-methyl tyrosine by gliomas and non-neoplastic brain lesions.

  1996cited by this paper
• [Results of positron emission tomography with fluorine-18 labeled fluorodeoxyglucose in differential diagnosis and staging of pancreatic carcinoma].

  1996cited by this paper
• Introduction to imaging brain tumor metabolism with positron emission tomography (PET).

  1995cited by this paper
• An exploration of the effects of L‐ and D‐tetrahydroisoquinoline‐3‐carboxylic acid substitutions at positions 2,3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin

  1995cited by this paper
• δ Opioidmimetic Antagonists: Prototypes for Designing a New Generation of Ultraselective Opioid Peptides

  1995cited by this paper
• Synthesis and biological activity of tripeptide FR113680 analogues containing unconventional amino acids

  1995cited by this paper
• F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer.

  1994cited by this paper
• Current imaging techniques for the evaluation of brain neoplasms.

  1994cited by this paper
• Analysis of neutral amino acid trasnport systems in the small intestine: A study of brush border membrane vesicles

  1991cited by this paper
• The applications of PET in clinical oncology.

  1991cited by this paper
• Transport of L-tyrosine by B16/F10 melanoma cells: the effect of the intracellular content of other amino acids.

  1990cited by this paper
• SPECT studies of brain tumors with L-3-[123I] iodo-alpha-methyl tyrosine: comparison with PET, 124IMT and first clinical results.

  1990cited by this paper
• Regiospecific Aromatic Radioiodination via No-Carrier-Added Copper(I) Chloride-Assisted Iododebromination

  1990cited by this paper
• Cerebral metabolism of L-[2-18F]fluorotyrosine, a new PET tracer of protein synthesis.

  1989cited by this paper
• Photoinhibition of 2-amino-2-carboxybicyclo[2,2,1]heptane transport by O-diazoacetyl-L-serine. An initial step in identifying the L-system amino acid transporter.

  1989cited by this paper
• Neutral amino acid transport at the human blood-brain barrier.

  1988cited by this paper
• Neutral amino acid transport systems in animal cells: Potential targets of oncogene action and regulators of cellular growth

  1988cited by this paper
• Neutral amino acid transport at the human blood-brain barrier.

  1986cited by this paper
• Development of a kit-form analog of metaiodobenzylguanidine.

  1986cited by this paper
• Tumor detection with carbon-11-labelled amino acids

  1984cited by this paper
• The regulation of neutral amino acid transport in mammalian cells.

  1983cited by this paper
• Effect of structure on tumor specificity of alicyclic alpha-amino acids.

  1978cited by this paper
• Uptake of 125I-labelled 4-iodophenylalanine in tumours of mice.

  1969cited by this paper
• Selective localization to pancreas of radioiodinated phenylalanine analogues.

  1968cited by this paper

• Leveraging Cancer Metabolism to Translate into Effective Therapeutics.

  2025cites this paper
• A Convenient Route to New (Radio)Fluorinated and (Radio)Iodinated Cyclic Tyrosine Analogs

  2022cites this paper
• Amino acid transport system - A substrate predicts the therapeutic effects of particle radiotherapy

  2017cites this paper
• Biological evaluation of new [(18) F]F-labeled synthetic amino acid derivatives as oncologic radiotracers.

  2016cites this paper
• Systemic treatment with 4-211At - phenylalanine enhances survival of rats with intracranial glioblastoma

  2013cites this paper
• Evaluation of (111)In-labeled macrocyclic chelator-amino acid derivatives for cancer imaging.

  2012cites this paper
• Brain Tumor Imaging Using p-[123I]Iodo-L-Phenylalanine and SPECT

  2011cites this paper
• An alternative and expedient synthesis of radioiodinated 4-iodophenylalanine.

  2011cites this paper
• Uptake of 3-[125I]iodo-alpha-methyl-L-tyrosine into colon cancer DLD-1 cells: characterization and inhibitory effect of natural amino acids and amino acid-like drugs.

  2010cites this paper
• Prospective study of p-[123I]iodo-L-phenylalanine and SPECT for the evaluation of newly diagnosed cerebral lesions: specific confirmation of glioma

  2010influential citation
• Synthesis, radiolabeling, and biological evaluation of (R)- and (S)-2-amino-3-[(18)F]fluoro-2-methylpropanoic acid (FAMP) and (R)- and (S)-3-[(18)F]fluoro-2-methyl-2-N-(methylamino)propanoic acid (NMeFAMP) as potential PET radioligands for imaging brain tumors.

  2010cites this paper
• Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug.

  2010cites this paper
• Synthesis and analysis of 2-[211At]-L-phenylalanine and 4-[211At]-L-phenylalanine and their uptake in human glioma cell cultures in-vitro.

  2010cites this paper
• Enhanced target-specific accumulation of radiolabeled antibodies by conjugating arginine-rich peptides as anchoring molecules.

  2010cites this paper
• Intracellular reactions affecting 2-amino-4-([(11)C]methylthio)butyric acid ([(11)C]methionine) response to carbon ion radiotherapy in C10 glioma cells.

  2009cites this paper
• PET imaging with p-[I-124]iodo-l-phenylalanine as a new tool for diagnosis and postoperative control in patients with glioma.

  2008cites this paper
• Improved synthesis of no-carrier-added p-[124I]iodo-L-phenylalanine and p-[131I]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomas.

  2008cites this paper
• Para-[(123)I]iodo-L-phenylalanine in patients with pancreatic adenocarcinoma: tumour uptake, whole-body kinetics, dosimetry.

  2008cites this paper
• Pancreatic Cancer: p-[123I]lodo-l-Phenylalanine Single Photon Emission Tomography for Tumor Imaging

  2008cites this paper
• Para-[123I]iodo-L-phenylalanine in patients with pancreatic adenocarcinoma

  2008cites this paper
• Facile stereospecific synthesis and biological evaluation of (S)- and (R)-2-amino-2-methyl-4-[123I]iodo-3-(E)-butenoic acid for brain tumor imaging with single photon emission computerized tomography.

  2007cites this paper
• In vitro und in vivo Untersuchungen zum zytotoxischen und radiosensitivierenden Potential von radioiodiertem Phenylalanin an experimentellen Glioblastommodellen

  2007cites this paper
• Use of [123I]-2-iodo-L-phenylalanine as a tumor imaging agent in two dogs with synovial cell sarcoma.

  2007cites this paper
• Intra-individual comparison of p-[123I]-iodo-L-phenylalanine and L-3-[123I]-iodo-α-methyl-tyrosine for SPECT imaging of gliomas

  2007cites this paper
• In vitro and in vivo magnetic resonance detection of tumor cells by targeting glutamine transporters with Gd-based probes.

  2006cites this paper
• Preparation and tumor affinity testing of the radioiodinated tetrahydroisoquinoline derivative [123I]TIC(OH) for targeting prostate cancer.

  2006cites this paper
• Radioiodinated phenylalanine derivatives to image pancreatic cancer: a comparative study with [18F]fluoro-2-deoxy-D-glucose in human pancreatic carcinoma xenografts and in inflammation models.

  2005cites this paper
• Validation of brain tumour imaging with p-[123I]iodo-l-phenylalanine and SPECT

  2005cites this paper
• In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT.

  2005cites this paper
• Action and efficacy of p-[131I]iodo-L-phenylalanine on primary human glioma cell cultures and rats with C6-gliomas.

  2004cites this paper
• p-[123I]iodo-l-phenylalanine for detection of pancreatic cancer: basic investigations of the uptake characteristics in primary human pancreatic tumour cells and evaluation in in vivo models of human pancreatic adenocarcinoma

  2004cites this paper
• Characterization of uptake of 3-[131I]iodo-α-methyl-L-tyrosine in human monocyte-macrophages

  2004cites this paper
• Characterization of uptake of 3-[(131)I]iodo-alpha-methyl-L-tyrosine in human monocyte-macrophages.

  2004cites this paper
• Pyrrolobenzimidazoles linked to heterocycles and peptides. Design of DNA base pair specific phosphate hydrolyzing agents and novel cytotoxic agents.

  2004cites this paper
• Radiopharmaceutical chemistry for positron emission tomography.

  2002cites this paper
• 3-[123I]Iodo-α-methyl-L-tyrosine: uptake mechanisms and clinical applications

  2002cites this paper
• Initial evaluation of the feasibility of single photon emission tomography with p-[123I]iodo-L-phenylalanine for routine brain tumour imaging

  2002cites this paper
• Clinical value of iodine-123-alpha-methyl-L-tyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up.

  2002cites this paper
• 3-[(123)I]Iodo-alpha-methyl-L-tyrosine: uptake mechanisms and clinical applications.

  2002cites this paper
• 3-[123I]Iodo-L-alpha-methyl tyrosine transport into human fibroblasts and comparison with Ewing's sarcoma cells.

  2002cites this paper
• Investigation of iodine-123-labelled amino acid derivatives for imaging cerebral gliomas: uptake in human glioma cells and evaluation in stereotactically implanted C6 glioma rats

  2000cites this paper